PEDv has caused significant losses for a number of years in the United States, China and Eastern Europe. Although it is now tapering off in the US, the status remains unchanged in China and Eastern Europe. In order to evaluate the possibilities of limiting this disease on an international level, Vitfoss decided earlier this year to have researchers look at whether Stalosan F, already known for being effective against PRRS virus as well as Salmonella and Lawsonia bacteria, has any effect against PEDv.